BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36985463)

  • 1. Solid-Liquid Equilibrium in Co-Amorphous Systems: Experiment and Prediction.
    Zemánková A; Hassouna F; Klajmon M; Fulem M
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purely Predicting the Pharmaceutical Solubility: What to Expect from PC-SAFT and COSMO-RS?
    Klajmon M
    Mol Pharm; 2022 Nov; 19(11):4212-4232. PubMed ID: 36136040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of Stable Co-Amorphous Drug-Drug Ratios from the Eutectic Behavior of Crystalline Physical Mixtures.
    Kissi EO; Khorami K; Rades T
    Pharmaceutics; 2019 Nov; 11(12):. PubMed ID: 31771255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Pharm Res; 2018 Jan; 35(1):25. PubMed ID: 29305717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical stability of API/polymer-blend amorphous solid dispersions.
    Lehmkemper K; Kyeremateng SO; Bartels M; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2018 Mar; 124():147-157. PubMed ID: 29269154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical stability of hydroxypropyl methylcellulose-based amorphous solid dispersions: Experimental and computational study.
    Iemtsev A; Hassouna F; Mathers A; Klajmon M; Dendisová M; Malinová L; Školáková T; Fulem M
    Int J Pharm; 2020 Nov; 589():119845. PubMed ID: 32931845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raman imaging of amorphous-amorphous phase separation in small molecule co-amorphous systems.
    Kilpeläinen T; Pajula K; Ervasti T; Uurasjärvi E; Koistinen A; Korhonen O
    Eur J Pharm Biopharm; 2020 Oct; 155():49-54. PubMed ID: 32795500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of the cooling rate and the blend ratio on the physical stability of co-amorphous naproxen/indomethacin.
    Beyer A; Grohganz H; Löbmann K; Rades T; Leopold CS
    Eur J Pharm Biopharm; 2016 Dec; 109():140-148. PubMed ID: 27746228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermodynamic Study of Molecular Interactions in Eutectic Mixtures Containing Camphene.
    Okuniewski M; Paduszyński K; Domańska U
    J Phys Chem B; 2016 Dec; 120(50):12928-12936. PubMed ID: 27936736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ionic vs. non-ionic excipients in APIs-based eutectic systems.
    Martins MAR; Silva LP; Jorge PS; Abranches DO; Pinho SP; Coutinho JAP
    Eur J Pharm Sci; 2021 Jan; 156():105583. PubMed ID: 33045368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Copolymer Properties on the Phase Behavior of Ibuprofen-PLA/PLGA Mixtures.
    Iemtsev A; Klajmon M; Hassouna F; Fulem M
    Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.
    Dohrn S; Luebbert C; Lehmkemper K; Kyeremateng SO; Degenhardt M; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():132-142. PubMed ID: 33212185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?
    Pavliš J; Mathers A; Fulem M; Klajmon M
    Mol Pharm; 2023 Aug; 20(8):3960-3974. PubMed ID: 37386723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of copolymer composition on the phase behavior of solid dispersions.
    Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
    Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solubility of pharmaceutical ingredients in triglycerides.
    Brinkmann J; Huxoll F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2019 Dec; 145():113-120. PubMed ID: 31682903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubility of Pharmaceutical Ingredients in Natural Edible Oils.
    Brinkmann J; Rest F; Luebbert C; Sadowski G
    Mol Pharm; 2020 Jul; 17(7):2499-2507. PubMed ID: 32369379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism.
    Dohrn S; Kyeremateng SO; Bochmann E; Sobich E; Wahl A; Liepold B; Sadowski G; Degenhardt M
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of DSC-Based Protocols for API-Polymer Solubility Determination.
    Mathers A; Hassouna F; Klajmon M; Fulem M
    Mol Pharm; 2021 Apr; 18(4):1742-1757. PubMed ID: 33656884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.
    Paus R; Ji Y; Vahle L; Sadowski G
    Mol Pharm; 2015 Aug; 12(8):2823-33. PubMed ID: 26107071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.